查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813226

2032 年肌肉刺激器市场预测：按产品类型、模式、技术、应用、最终用户和地区进行的全球分析

Muscle Stimulators Market Forecasts to 2032 - Global Analysis By Product Type, Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球肌肉刺激设备市场预计在 2025 年达到 8.5483 亿美元，到 2032 年将达到 11.4781 亿美元，预测期内的复合年增长率为 4.3%。

神经肌肉电刺激设备(NMES) 设备，又称为肌肉刺激器，因其能够透过受控电脉衝诱发肌肉收缩，在復健和运动科学领域备受关注。其在增强肌肉、促进伤后恢復以及预防固定患者肌肉萎缩方面的效用已得到公认。研究表明，持续、有针对性的刺激可以改善运动功能，促进神经肌肉的再训练，尤其是在术后和神经系统病例中。然而，优化频率、强度和脉衝持续时间等参数对于确保疗效和患者安全至关重要。正在进行的研究旨在改进这些设备，使其能够应用于更广泛的临床和运动领域。

根据世界卫生组织 (WHO) 统计，到 2022 年，全球将有约 17.1 亿人患有肌肉骨骼疾病，成为全球首要残疾原因。仅腰痛一项，就是 160 个国家首要的残疾原因。

肌肉骨骼疾病盛行率上升

关节炎、背痛和肌肉损伤等肌肉骨骼疾病的发生率不断上升，是肌肉刺激器市场的主要驱动力。由于这些疾病会损害活动能力并降低生活质量，医疗保健提供者和患者正在寻求非侵入性解决方案来恢復肌肉功能。肌肉刺激器能够发出定向电脉衝，帮助增强虚弱的肌肉并改善復原效果。研究表明，持续使用可以增强活动能力并加快康復速度。因此，全球肌肉骨骼疾病负担日益加重，对有效且便捷的復健技术的需求日益强烈，这使得肌肉刺激器成为临床和家庭环境中的首选治疗方案。

设备成本高

肌肉刺激器相对较高的成本严重限制了市场扩张，尤其是在新兴市场。具有无线功能、应用程式整合或基于人工智慧的客製化功能的先进神经肌肉电刺激 (NMES) 设备需要大量的製造投资，导致最终用户的价格高昂。对于许多患者和小型诊所来说，这些成本可能过高，限制了其普及。此外，对于预算有限的医院和復健中心来说，高昂的初始投资可能会推迟采购。经济差距进一步加剧了这个问题，降低了低收入群体的可及性。因此，儘管肌肉刺激器具有临床益处，但高昂的经济负担仍然限制了其普及，并减缓了整体市场的成长。

扩大家庭復健计划

居家復健计画发展势头强劲，尤其是在新冠疫情之后，这为肌肉刺激器带来了巨大的成长机会。患者越来越青睐便利、非侵入式且可在远端监控下独立进行的疗法。肌肉刺激器有助于持续进行有针对性的锻炼，并减少临床依赖。研究强调了其在改善术后或固定患者功能恢復和维持肌肉质量方面的有效性。与远端医疗平台和基于应用程式的指导相结合，可增强可用性和患者参与度。随着医疗保健系统越来越多地采用分散式护理模式，家用神经肌肉电刺激 (NMES) 设备的普及率预计将不断扩大，这将为製造商提供开发易于使用、便携且互联互通的解决方案的机会。

副作用和病人安全问题

肌肉刺激器的使用受到潜在副作用的严重威胁，这些副作用包括皮肤刺激、肌肉疲劳和刺激不当。不良的患者体验会降低使用者和临床医生的信心，并限制其市场渗透。在家中使用不当且缺乏适当监督会加剧这些担忧。此外，某些族群（例如患有严重神经病变或合併症的患者）的临床结果并不一致，可能会损害人们对神经肌肉电刺激 (NMES) 有效性的认知。医疗保健提供者可能不愿意推荐没有完善安全规程的设备，监管机构也可能实施更严格的指导方针。因此，为了减轻这种威胁，透过病患教育、培训和设备创新来解决安全问题至关重要。

COVID-19的影响：

新冠疫情对肌肉刺激设备市场产生了双重影响。一方面，医院关闭和就诊人数减少导致供应链暂时中断，临床復健服务的可近性受限，导致设备采用率短期内下降。另一方面，疫情加速了向家庭復健和远端医疗的转变，为可携式、易于使用的神经肌肉电刺激 (NMES) 设备创造了新的机会。正在从新冠疫情相关的肌肉无力和长期制动中恢復的患者越来越多地寻求非侵入性治疗方法来恢復力量和活动能力。因此，儘管初期市场活动遭遇挫折，但长期趋势有利于家庭设备和远端监控解决方案的成长，凸显了疫情在该领域发挥的变革性作用。

经皮电刺激 (TENS) 细分市场预计将成为预测期内最大的细分市场

预计经皮神经电刺激 (TENS) 领域将在预测期内占据最大的市场份额。这一增长主要得益于 TENS 在非侵入性疼痛管理中的广泛应用，可有效缓解关节炎、下背痛和肌肉痛等症状。 TENS 的易用性、价格实惠以及临床和家庭适用性进一步推动了其受欢迎程度。慢性疼痛疾病的盛行率不断上升以及人们对非药物治疗方法的日益青睐，是 TENS 占据市场领先地位的重要因素。随着医疗保健系统日益重视非药物疗法，TENS 继续受到患者和医疗服务提供者的青睐。

疼痛管理领域预计将在预测期内以最高的复合年增长率成长

预计疼痛管理领域将在预测期内实现最高成长率。这一增长主要源于关节炎和腰痛等慢性疼痛疾病的日益流行，以及人们对非侵入性、无药物治疗方案的日益青睐。肌肉刺激器，尤其是经皮神经电刺激 (TENS) 设备，在寻求有效缓解疼痛且避免药物治疗副作用的患者中越来越受欢迎。此外，设备技术的进步，包括便携性和用户友好介面的改进，进一步促进了该领域的扩张，从而提高了患者的依从性和满意度。

占比最大的地区：

预计北美将在预测期内占据最大的市场份额。这项优势归功于多种因素，包括先进的医疗基础设施、肌肉骨骼和神经系统疾病的高发病率以及创新医疗技术的广泛应用。美国尤其凭藉其在医疗保健研发方面的巨额投资、医疗设备的高利用率以及支持使用先进肌肉刺激设备的完善医疗保健体系，引领市场。此外，患者和医疗服务提供者对疼痛管理和復健疗法的认识不断提高，也有助于该地区巩固市场领导地位。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。这一增长的主要驱动力包括人们的健康意识不断增强、疼痛管理疗法的普及以及用于维护健康的智慧型装置的使用日益增多。此外，该地区运动伤害的激增，进一步刺激了对肌肉刺激设备的需求。印度等国家预计将实现显着成长，这得益于其不断扩大的医疗基础设施以及大量寻求非侵入性治疗方案的患者。这些因素共同使亚太地区成为肌肉刺激设备成长最快的区域市场。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球肌肉刺激器市场（依产品类型）

  • 经皮电刺激（TENS）
  • 功能性电刺激（FES）
  • 电肌肉刺激（EMS）
  • 神经肌肉电刺激（NMES）

6. 全球肌肉刺激设备市场（按模式）

  • 可携式/桌上型系统
  • 手持装置

7. 全球肌肉刺激设备市场（依技术）

  • 模拟
  • 数位的
  • 无线/智慧集成

第八章全球肌肉刺激器市场（按应用）

  • 疼痛管理
  • 復原
  • 肌肉强化
  • 提升运动表现

9. 全球肌肉刺激器市场（按最终用户）

  • 医院
  • 物理治疗诊所
  • 居家医疗
  • 运动诊所/运动中心

第 10 章全球肌肉刺激器市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第 12 章：公司概况

  • Abbott Laboratories
  • AxioBionics
  • Beurer
  • BioMedical Life Systems
  • BTL
  • Chattanooga（DJO）
  • Compex
  • EMS Physio
  • Enovis Corporation（DJO）
  • GAMA Healthcare
  • Globus Corporation
  • Ito Physiotherapy & Rehabilitation
  • Liberate Medical
  • Mettler Electronics
  • NeuroMetrix
Product Code: SMRC30685

According to Stratistics MRC, the Global Muscle Stimulators Market is accounted for $854.83 million in 2025 and is expected to reach $1147.81 million by 2032 growing at a CAGR of 4.3% during the forecast period. Muscle stimulators, or neuromuscular electrical stimulation (NMES) devices, have garnered significant attention in rehabilitation and sports science for their ability to evoke muscle contractions through controlled electrical impulses. As a research associate, I recognize their utility in enhancing muscle strength, accelerating recovery after injury, and preventing atrophy in immobilized patients. Studies indicate that consistent, targeted stimulation can improve motor function and facilitate neuromuscular re-education, particularly in post-operative or neurological cases. However, optimizing parameters such as frequency, intensity, and pulse duration is critical to ensure efficacy and patient safety. Ongoing investigations aim to refine these devices for broader clinical and athletic applications.

According to the World Health Organization (WHO), in 2022, approximately 1.71 billion people globally were affected by musculoskeletal conditions, making them the leading cause of disability worldwide. Low back pain alone was the top cause of disability in 160 countries.

Market Dynamics:

Driver:

Rising prevalence of musculoskeletal disorders

The increasing incidence of musculoskeletal disorders, such as arthritis, back pain, and muscle injuries, is a significant driver for the muscle stimulators market. As these conditions impair mobility and reduce quality of life, healthcare providers and patients seek non-invasive solutions to restore muscle function. Muscle stimulators offer targeted electrical impulses that aid in strengthening weakened muscles and improving rehabilitation outcomes. Studies have shown that consistent use enhances motor function and accelerates recovery. Consequently, the growing burden of musculoskeletal conditions globally creates a strong demand for effective and convenient rehabilitation technologies, positioning muscle stimulators as a preferred therapeutic solution in clinical and home settings.

Restraint:

High device costs

The relatively high cost of muscle stimulators is a major restraint for market expansion, particularly in developing regions. Advanced NMES devices with wireless capabilities, app integration, or AI-based customization require significant manufacturing investment, which translates to higher prices for end-users. Many patients and smaller clinics may find these costs prohibitive, limiting adoption. Additionally, high initial investments can slow procurement in hospitals or rehabilitation centers, where budgets are constrained. Economic disparities further exacerbate this issue, reducing accessibility in low-income populations. Consequently, despite their clinical benefits, the financial burden associated with muscle stimulators continues to restrict widespread uptake and slows overall market growth.

Opportunity:

Expansion of home-based rehabilitation programs

Home-based rehabilitation programs have gained momentum, particularly after the COVID-19 pandemic, presenting a substantial growth opportunity for muscle stimulators. Patients increasingly prefer convenient, non-invasive therapies that can be administered independently under remote supervision. Muscle stimulators facilitate consistent, targeted exercise, reducing dependency on clinical visits. Research underscores their effectiveness in improving functional recovery and maintaining muscle mass in post-operative or immobilized patients. Integration with telehealth platforms and app-based guidance enhances usability and patient engagement. As healthcare systems increasingly embrace decentralized care models, the adoption of home-use NMES devices is poised to grow, offering manufacturers opportunities to develop user-friendly, portable, and connected solutions.

Threat:

Side effects and patient safety concerns

The use of muscle stimulators is seriously threatened by possible side effects, such as skin irritation, muscle fatigue, or inappropriate stimulation. Negative patient experiences can reduce confidence among users and clinicians, limiting market penetration. Misuse at home without adequate supervision can exacerbate these concerns. Additionally, inconsistent clinical outcomes in specific populations, such as patients with severe neurological deficits or comorbidities, may undermine the perceived efficacy of NMES. Healthcare providers may hesitate to recommend devices without robust safety protocols, and regulatory authorities may impose stricter guidelines. Addressing safety concerns through patient education, training, and device innovation is therefore critical to mitigating this threat.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the muscle stimulators market. On one hand, lockdowns and reduced hospital visits temporarily disrupted supply chains and limited access to clinical rehabilitation services, causing short-term declines in device adoption. On the other hand, the pandemic accelerated the shift toward home-based rehabilitation and telehealth, creating new opportunities for portable and user-friendly NMES devices. Patients recovering from COVID-19-related muscle weakness or prolonged immobilization increasingly sought non-invasive therapies to restore strength and mobility. Consequently, while initial market activity faced setbacks, the long-term trend favored growth in home-use devices and remote monitoring solutions, highlighting the pandemic's transformative effect on the sector.

The transcutaneous electrical nerve stimulation (TENS) segment is expected to be the largest during the forecast period

The transcutaneous electrical nerve stimulation (TENS) segment is expected to account for the largest market share during the forecast period. This prominence is primarily attributed to TENS's widespread application in non-invasive pain management, offering effective relief for conditions such as arthritis, back pain, and muscle soreness. Its popularity is further bolstered by its ease of use, affordability, and suitability for both clinical and home settings. The increasing prevalence of chronic pain disorders and a growing preference for drug-free therapeutic options have significantly contributed to TENS's market leadership. As healthcare systems emphasize non-pharmacological treatments, TENS continues to be a preferred choice among patients and healthcare providers alike.

The pain management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pain management segment is predicted to witness the highest growth rate. This growth is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis and back pain, and a growing preference for non-invasive, drug-free therapeutic options. Muscle stimulators, particularly Transcutaneous Electrical Nerve Stimulation (TENS) devices, have gained popularity among patients seeking effective pain relief without the side effects associated with pharmacological treatments. Furthermore, the segment's expansion is further supported by advancements in device technology, including portability and user-friendly interfaces, which enhance patient compliance and satisfaction.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This dominance is attributed to several factors, including advanced healthcare infrastructure, high prevalence of musculoskeletal and neurological disorders, and strong adoption of innovative medical technologies. The United States, in particular, leads the market due to substantial investments in healthcare research and development, a high rate of medical device utilization, and a well-established healthcare system that supports the use of advanced muscle stimulators. Additionally, the growing awareness of pain management and rehabilitation therapies among patients and healthcare providers further contributes to the region's leading position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This growth is primarily driven by increasing awareness of health and wellness, a rising adoption of pain management treatments, and the growing use of smart devices for maintaining health. Additionally, the region is witnessing a surge in sports-related injuries, further fueling the demand for muscle stimulators. Countries like India are expected to register significant growth due to expanding healthcare infrastructure and a large patient population seeking non-invasive therapeutic solutions. The combination of these factors positions Asia Pacific as the fastest-growing regional market for muscle stimulators.

Key players in the market

Some of the key players in Muscle Stimulators Market include Abbott Laboratories, AxioBionics, Beurer, BioMedical Life Systems, BTL, Chattanooga (DJO), Compex, EMS Physio, Enovis Corporation (DJO), GAMA Healthcare, Globus Corporation, Ito Physiotherapy & Rehabilitation, Liberate Medical, Mettler Electronics and NeuroMetrix.

Key Developments:

In February 2025, Globus Medical and Nevro Corp. announced they have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of directors of both companies, Globus Medical will acquire all shares of Nevro for $5.85 per share.

In December 2024, Abbott Laboratories and DexCom said they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

In October 2024, PT Beurer Indonesia Technology, a subsidiary of German healthcare device manufacturer Beurer GmbH, has opened a factory at the Kendal Special Economic Zone (KEK) in Central Java, making it the first such production facility in Southeast Asia. The company's decision to expand to Indonesia was formalized, when Beurer signed an investment agreement with KEK Kendal at the Hannover Messe event in Germany.

Product Types Covered:

  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Functional Electrical Stimulation (FES)
  • Electrical Muscle Stimulation (EMS)
  • Neuromuscular Electrical Stimulation (NMES)

Modalities Covered:

  • Portable/Bench-top Systems
  • Handheld Devices

Technologies Covered:

  • Analog
  • Digital
  • Wireless / Smart-integrated

Applications Covered:

  • Pain Management
  • Rehabilitation
  • Muscle Strengthening
  • Athletic Performance Enhancement

End Users Covered:

  • Hospitals
  • Physiotherapy Clinics
  • Home Care Settings
  • Sports Clinics / Athletic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Muscle Stimulators Market, By Product Type

  • 5.1 Introduction
  • 5.2 Transcutaneous Electrical Nerve Stimulation (TENS)
  • 5.3 Functional Electrical Stimulation (FES)
  • 5.4 Electrical Muscle Stimulation (EMS)
  • 5.5 Neuromuscular Electrical Stimulation (NMES)

6 Global Muscle Stimulators Market, By Modality

  • 6.1 Introduction
  • 6.2 Portable/Bench-top Systems
  • 6.3 Handheld Devices

7 Global Muscle Stimulators Market, By Technology

  • 7.1 Introduction
  • 7.2 Analog
  • 7.3 Digital
  • 7.4 Wireless / Smart-integrated

8 Global Muscle Stimulators Market, By Application

  • 8.1 Introduction
  • 8.2 Pain Management
  • 8.3 Rehabilitation
  • 8.4 Muscle Strengthening
  • 8.5 Athletic Performance Enhancement

9 Global Muscle Stimulators Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Physiotherapy Clinics
  • 9.4 Home Care Settings
  • 9.5 Sports Clinics / Athletic Centers

10 Global Muscle Stimulators Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 AxioBionics
  • 12.3 Beurer
  • 12.4 BioMedical Life Systems
  • 12.5 BTL
  • 12.6 Chattanooga (DJO)
  • 12.7 Compex
  • 12.8 EMS Physio
  • 12.9 Enovis Corporation (DJO)
  • 12.10 GAMA Healthcare
  • 12.11 Globus Corporation
  • 12.12 Ito Physiotherapy & Rehabilitation
  • 12.13 Liberate Medical
  • 12.14 Mettler Electronics
  • 12.15 NeuroMetrix

List of Tables

  • Table 1 Global Muscle Stimulators Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Muscle Stimulators Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Muscle Stimulators Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2024-2032) ($MN)
  • Table 4 Global Muscle Stimulators Market Outlook, By Functional Electrical Stimulation (FES) (2024-2032) ($MN)
  • Table 5 Global Muscle Stimulators Market Outlook, By Electrical Muscle Stimulation (EMS) (2024-2032) ($MN)
  • Table 6 Global Muscle Stimulators Market Outlook, By Neuromuscular Electrical Stimulation (NMES) (2024-2032) ($MN)
  • Table 7 Global Muscle Stimulators Market Outlook, By Modality (2024-2032) ($MN)
  • Table 8 Global Muscle Stimulators Market Outlook, By Portable/Bench-top Systems (2024-2032) ($MN)
  • Table 9 Global Muscle Stimulators Market Outlook, By Handheld Devices (2024-2032) ($MN)
  • Table 10 Global Muscle Stimulators Market Outlook, By Technology (2024-2032) ($MN)
  • Table 11 Global Muscle Stimulators Market Outlook, By Analog (2024-2032) ($MN)
  • Table 12 Global Muscle Stimulators Market Outlook, By Digital (2024-2032) ($MN)
  • Table 13 Global Muscle Stimulators Market Outlook, By Wireless / Smart-integrated (2024-2032) ($MN)
  • Table 14 Global Muscle Stimulators Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Muscle Stimulators Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 16 Global Muscle Stimulators Market Outlook, By Rehabilitation (2024-2032) ($MN)
  • Table 17 Global Muscle Stimulators Market Outlook, By Muscle Strengthening (2024-2032) ($MN)
  • Table 18 Global Muscle Stimulators Market Outlook, By Athletic Performance Enhancement (2024-2032) ($MN)
  • Table 19 Global Muscle Stimulators Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Muscle Stimulators Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 21 Global Muscle Stimulators Market Outlook, By Physiotherapy Clinics (2024-2032) ($MN)
  • Table 22 Global Muscle Stimulators Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 23 Global Muscle Stimulators Market Outlook, By Sports Clinics / Athletic Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.